A STUDY ON NON ALCHOLIC FATTY LIVER DISEASE

A RANDOMISED, PROSPECTIVE, PARALLEL AND OPEN LABEL STUDY TO COMPARE EFFICACY AND SAFETY OF SYNBIOTICS WITH TOCOTRIENOL IN NON ALCHOLIC FATTY LIVER DISEASE

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057604

Enrollment

Registered

2023-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: SYNBIOTIC: PREBIOTIC + PROBIOTIC CAPSULE OF 5 BCFU TWICE DAILY Intervention2: VITAMIN E: 200mg TWICE DAILY Intervention3: Synbiotic: Prebiotics and Probiotics combination of 5 BCFU give

Eligibility

Inclusion criteria

Inclusion criteria: NAFLD diagnosed by suggestive imaging findings ( ultrasound) with / without abnormal aminotransferase levels

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Endstage liver disease Patients Patients with Hepatitis B and C

Design outcomes

Primary

Measure	Time frame
Liver Function TestsTimepoint: 0, 30, 60, 90 days	—

Secondary

Measure	Time frame
Anthropometric parametersTimepoint: 0,30,60,90 days	—

Countries

India

Contacts

Public ContactDr Khushbakht Kaur Dhaliwal

GOVERNMENT MEDICAL COLLEGE

kullar.g@gmail.com9501009338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026